Sam­sung Bio pulls in $1.06B man­u­fac­tur­ing deal with un­named US phar­ma com­pa­ny

Sam­sung Bi­o­log­ics has signed a man­u­fac­tur­ing con­tract worth 1.46 tril­lion won ($1.06 bil­lion) with an un­named “large” US phar­ma­ceu­ti­cal com­pa­ny, mak­ing this at least the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.